SCALA: a randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis.
Saved in:
| Title: | SCALA: a randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis. |
|---|---|
| Authors: | Montalban X; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Passeig Vall d'Hebron 119-129, Edifici Cemcat, Barcelona 08035, Spain., Rodriguez-Acevedo B; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Barcelona, Spain., Nos C; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Barcelona, Spain., Resina M; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Barcelona, Spain., Forner M; Sanofi, Barcelona, Spain., Wu Y; Sanofi, Beijing, China., Chirieac M; Sanofi, Cambridge, MA, USA. |
| Source: | Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2024 Nov 06; Vol. 17, pp. 17562864241291655. Date of Electronic Publication: 2024 Nov 06 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Country of Publication: England NLM ID: 101480242 Publication Model: eCollection Cited Medium: Print ISSN: 1756-2856 (Print) Linking ISSN: 17562856 NLM ISO Abbreviation: Ther Adv Neurol Disord Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
